Dennis T. Brown
Corporate Officer/Principal presso North Carolina State University
Profilo
Dennis T.
Brown is the founder of Arbovax, Inc. founded in 2005.
Currently, he is a Professor & Head-Molecular at North Carolina State University since 1997.
Previously, he worked as an Assistant Professor at Dartmouth College, a Professor-Microbiology at The University of Texas at Austin, an Associate Professor-Medical Pharmacology at the University of Maryland, and a Professor-Genetics at Universität zu Köln.
He received his doctorate degree from the University of Pennsylvania in 1967.
Posizioni attive di Dennis T. Brown
Società | Posizione | Inizio |
---|---|---|
North Carolina State University | Corporate Officer/Principal | 01/01/1997 |
Precedenti posizioni note di Dennis T. Brown
Società | Posizione | Fine |
---|---|---|
The University of Texas at Austin | Corporate Officer/Principal | - |
Universität zu Köln | Corporate Officer/Principal | - |
Dartmouth College | Corporate Officer/Principal | - |
University of Maryland | Corporate Officer/Principal | - |
Arbovax, Inc.
Arbovax, Inc. Pharmaceuticals: MajorHealth Technology Arbovax, Inc. engages in the research and development of vaccines against arthropod-borne diseases. The firm facilitates development of vaccines against insect-borne viruses and focuses on dengue fever, chikungunya fever, west Nile virus, and veterinary markets. The company was founded by Malcolm E. Thomas, Jonathan Lawrie, Brown T. Dennis and Raquel Hernandez in October 2005 and is headquartered in Raleigh, NC. | Fondatore | - |
Formazione di Dennis T. Brown
University of Pennsylvania | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Arbovax, Inc.
Arbovax, Inc. Pharmaceuticals: MajorHealth Technology Arbovax, Inc. engages in the research and development of vaccines against arthropod-borne diseases. The firm facilitates development of vaccines against insect-borne viruses and focuses on dengue fever, chikungunya fever, west Nile virus, and veterinary markets. The company was founded by Malcolm E. Thomas, Jonathan Lawrie, Brown T. Dennis and Raquel Hernandez in October 2005 and is headquartered in Raleigh, NC. | Health Technology |
- Borsa valori
- Insiders
- Dennis T. Brown